BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19717376)

  • 1. Mantle cell lymphoma: biological insights and treatment advances.
    Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphoma in relapse: the role of emerging new drugs.
    Diefenbach CS; O'Connor OA
    Curr Opin Oncol; 2010 Sep; 22(5):419-23. PubMed ID: 20679769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the molecular biology of mantle cell lymphoma.
    Bertoni F; Rinaldi A; Zucca E; Cavalli F
    Hematol Oncol; 2006 Mar; 24(1):22-7. PubMed ID: 16402392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of mantle cell lymphoma: key challenges and next steps.
    Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment approaches for mantle-cell lymphoma.
    Witzig TE
    J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.
    Jares P; Colomer D; Campo E
    Nat Rev Cancer; 2007 Oct; 7(10):750-62. PubMed ID: 17891190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of mantle cell lymphoma: current approach and future directions.
    Brody J; Advani R
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
    Dreyling M; Hiddemann W
    Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.
    Obrador-Hevia A; Fernández de Mattos S; Villalonga P; Rodríguez J
    Blood Rev; 2009 Sep; 23(5):205-16. PubMed ID: 19362399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-based therapy for mantle cell lymphoma.
    Munger CM; Vose JM; Joshi SS
    Int J Oncol; 2006 Jun; 28(6):1337-43. PubMed ID: 16685434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma: advances in biology and therapy.
    Smith MR
    Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
    Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI
    Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
    Lenz G; Dreyling M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: established therapeutic options and future directions.
    Lenz G; Dreyling M; Hiddemann W
    Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of mantle cell lymphoma.
    Menanteau MR; Martinez-Climent JA
    Methods Mol Biol; 2013; 973():147-63. PubMed ID: 23412788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
    Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
    Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.